We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Probe Identifies Proteins Related to Aging Conditions

By LabMedica International staff writers
Posted on 04 Sep 2009
Scientists have developed a powerful new probe for identifying proteins affected by a key chemical process in aging and disease. More...
The probe works like a molecular navigation system for finding the proteins in cells. It could lead to new insights into disease processes and identify new targets for disease treatments.

The technology developed by the scientists has applications in both diagnostics (protein biomarkers), and in clinical medicine where it has a role in inhibition of enzymes implicated in diseases such as cancer and diabetes.

A new molecule called DAz-2 was developed that quickly finds specific proteins affected by reactive oxygen species (ROS). The molecules do this by chemically "tagging” sulfenic acid. Formed in cells, sulfenic acid indicates that a protein has undergone an oxidation reaction caused by the ROS. In laboratory studies using cultured cells, the scientists identified more than 190 proteins that had undergone this reaction.

Kate Carroll and colleagues from the chemistry department, University of Michigan (Ann Arbor, MI, USA) noted that scientists have known for years that the excess build-up of highly-reactive oxygen-containing molecules in cells contribute to aging disorders, possibly even cancer and Alzheimer's disease (AD). Many believe that a diet rich in antioxidants, which are abundant in fruits and vegetables, help deter this cell-damaging process by blocking the accumulation of these ROS molecules. But scientists have lacked the proper tools to study the effects of these molecules in detail.

The study is scheduled for publication in the September 18, 2009, issue of the American Chemical Society (ACS) journal Chemical Biology.

Related Links:

Chemistry department, University of Michigan




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.